MULTIPLE ENDOCRINE NEOPLASIA TYPE 2
Clinical trials for MULTIPLE ENDOCRINE NEOPLASIA TYPE 2 explained in plain language.
Never miss a new study
Get alerted when new MULTIPLE ENDOCRINE NEOPLASIA TYPE 2 trials appear
Sign up with your email to follow new studies for MULTIPLE ENDOCRINE NEOPLASIA TYPE 2, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can Full-Body scans spot cancer early in High-Risk families?
Diagnosis OngoingThis study is testing whether whole body MRI scans can help find cancers early in children and adults with Li-Fraumeni syndrome, a genetic condition that greatly raises cancer risk. About 150 participants will receive annual whole body MRI scans for four years to see if they keep…
Matched conditions: MULTIPLE ENDOCRINE NEOPLASIA TYPE 2
Phase: NA • Sponsor: Dana-Farber Cancer Institute • Aim: Diagnosis
Last updated Jun 27, 2026 08:08 UTC
-
Researchers launch registry to track rare endocrine tumors
Knowledge-focused OngoingThis study gathers health questionnaires from up to 1,500 people with multiple endocrine neoplasia (MEN1 or MEN2) and their close relatives. The goal is to build a database that helps researchers better understand these rare inherited conditions. No new treatments or procedures a…
Matched conditions: MULTIPLE ENDOCRINE NEOPLASIA TYPE 2
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC